Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study

BMC Cancer
E LinDanielle Crawley

Abstract

Prostate cancer (PCa) and type 2 diabetes mellitus (T2DM) are prevalent conditions that often occur concomitantly. However, many aspects of the impact of T2DM, particularly the duration of T2DM and antidiabetic medications, on PCa risk are poorly understood. To assess the association of duration of T2DM and antidiabetic medication with PCa risk, we designed a matched case-control study, including 31,415 men with PCa and 154,812 PCa-free men in Prostate Cancer data Base Sweden (PCBaSe) 4.1. Overall, a decreased risk of PCa was observed for men with T2DM (odds ratio (OR): 0.81, 95% confidence interval (CI): 0.78-0.84), as compared to men without T2DM. The decreased risk of PCa was consistently showed across duration of T2DM. With respect to use of antidiabetic drugs, this inverse association with duration was also found for all medications types, as compared to men without T2DM, including insulin, metformin and sulphonylurea (SU) (e.g. 3- < 5 yr insulin OR:0.69, 95%CI:0.60-0.80; 3- < 5 yr metformin OR: 0.82, 95%CI: 0.74-0.91; 3- < 5 yr SU OR: 0.72, 95%CI: 0.62-0.83). When stratifying by PCa risk categories, this decreased risk was most evident for diagnosis of low and intermediate-risk PCa (low-risk OR: 0.65, 95%CI: 0.66-0.70, in...Continue Reading

References

Sep 27, 2005·Cancer Causes & Control : CCC·A González-Pérez, L A García Rodríguez
Nov 23, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jocelyn S Kasper, Edward Giovannucci
Aug 14, 2008·American Journal of Epidemiology·Teemu J MurtolaAnssi Auvinen
Aug 5, 2009·Cancer Causes & Control : CCC·Jonathan L Wright, Janet L Stanford
Mar 17, 2010·Cancer Causes & Control : CCC·Qiang LiIchiro Tsuji
May 13, 2011·Cancer Causes & Control : CCC·Daniel M MoreiraStephen J Freedland
Jul 15, 2011·Diabetology & Metabolic Syndrome·Hans-Werner HenseWolf U Batzler
Sep 7, 2011·Prostate Cancer and Prostatic Diseases·K A MosesM M Issa
May 9, 2012·International Journal of Epidemiology·Mieke Van HemelrijckUNKNOWN NPCR and PCBaSe Sweden
Aug 16, 2012·European Journal of Endocrinology·Dianna J MaglianoTimothy M E Davis
Oct 4, 2012·Prostate Cancer and Prostatic Diseases·D BansalP Tiwari
Jan 29, 2013·Cancer Epidemiology·Pengpeng ZhangShumei Wang
Feb 13, 2013·Prostate Cancer and Prostatic Diseases·Y R LawrenceI Wolf
Feb 15, 2013·The Journal of Clinical Endocrinology and Metabolism·Gabriel Y LaiNeal D Freedman
Apr 13, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Katja FallBjörn Zethelius
Jul 16, 2013·Journal of the National Cancer Institute·David MargelNeil Fleshner
Aug 7, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David MargelNeil Fleshner
Nov 10, 2013·Nature Medicine·Wai Leong Tam, Robert A Weinberg
May 27, 2014·European Urology·Mark A PrestonHenrik T Sørensen
May 28, 2014·International Journal of Cancer. Journal International Du Cancer·Konstantinos K TsilidisTimothy J Key
Sep 10, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Chin-Hsiao Tseng
Jan 22, 2015·BJU International·Mieke Van HemelrijckPär Stattin
Mar 3, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Tobias NordströmHenrik Grönberg
Jun 4, 2016·American Journal of Epidemiology·Rachel DanknerLaurence S Freedman
Aug 26, 2016·International Journal of Cancer. Journal International Du Cancer·Danielle CrawleyMieke Van Hemelrijck
Nov 4, 2016·International Journal of Cancer. Journal International Du Cancer·Christel HäggströmPär Stattin
Aug 2, 2018·Cancer Biology & Therapy·Andreas PircherIsabel Heidegger
May 16, 2019·Journal of the National Comprehensive Cancer Network : JNCCN·James L MohlerDeborah A Freedman-Cass

❮ Previous
Next ❯

Citations

Apr 9, 2021·The World Journal of Men's Health·Chin-Hsiao Tseng
Oct 4, 2021·Prostate Cancer and Prostatic Diseases·Rocío Barrios-RodríguezJosé Juan Jiménez-Moleón

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.